KIFAP3 polymorphisms and survival in ALS.

The article discusses research on the relationship between Kinesin-Associated Protein 3 polymorphisms and the rate of survival among patients with Amyotrophic Lateral Sclerosis (ALS). It references the study "Reduced Expression of the Kinesin-Associated Protein 3 (KIFAP3) Gene Increases Survival in Sporadic Amyotrophic Lateral Sclerosis," by John E. Landers et al, published in the 2009 issue of the periodical "Proceedings of the National Academy of Sciences in the United States of America." The study involved patients from the U.S. and Europe.